FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 340:367-373 February 4, 1999 Number 5 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF Purchase this article Editorial by Campion, E. W. Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Tuberculosis remains an important problem in patients with human immunodeficiency virus (HIV) infection in the United States, with an estimated 6000 to 9000 new cases annually.¹ The case rates are extraordinarily high among indigent patients and substance abusers, and one third of these patients are also infected with HIV.² Much has been learned about the pathogenesis, clinical presentation, treatment, and prevention of tuberculosis in HIV-infected persons over the past several years. We summarize recent developments in these areas, as well as the effects of new antiretroviral therapies on antituberculosis regimens.

HIV Infection and Susceptibility to Tuberculosis

HIV-infected persons are at markedly increased risk for primary or . . . [Full Text of this Article]

Tuberculosis and the Course of HIV Infection

Testing for HIV Infection in Patients with Tuberculosis

Clinical Presentation and Radiographic Findings

Rapid Diagnostic Tests

Restriction-Fragment–Length Polymorphism Analysis

Treatment of Tuberculosis

Paradoxical Reactions during Antituberculosis Therapy

Resistance to Rifampin

Multidrug-Resistant Tuberculosis

Malabsorption of Antituberculosis Medications

Chemoprophylaxis and Anergy Testing

Source Information

From the Department of Medicine, University of California at San Diego, San Diego (D.V.H.); and the Center for Pulmonary and Infectious Disease Control, University of Texas Health Center, Tyler (P.F.B.).

Address reprint requests to Dr. Barnes at the CPIDC, University of Texas Health Center, 11937 U.S. Hwy. 271, Tyler, TX 75708-3154, or at pbarnes@uthct.edu.

References

This article has been cited by other articles:

• Kruijshaar, M E, Abubakar, I (2009). Increase in extrapulmonary tuberculosis in England and Wales 1999-2006. Thorax 64: 1090-1095 [Abstract] [Full Text]  
• Stone, V. E., Bounds, B. C., Muse, V. V., Ferry, J. A. (2009). Case 29-2009 -- An 81-Year-Old Man with Weight Loss, Odynophagia, and Failure to Thrive. NEJM 361: 1189-1198 [Full Text]  
• Day, J., Friedman, A., Schlesinger, L. S. (2009). Modeling the immune rheostat of macrophages in the lung in response to infection. Proc. Natl. Acad. Sci. USA 106: 11246-11251 [Abstract] [Full Text]  
• Karam, G. H. (2009). Infections in AIDS Patients and Other Immunocompromised Hosts. ACCP Crit Care Med Brd Rev 20: 13-40 [Full Text]  
• Dinser, R., Fousse, M., Sester, U., Albrecht, K., Singh, M., Kohler, H., Muller-Ladner, U., Sester, M. (2008). Evaluation of latent tuberculosis infection in patients with inflammatory arthropathies before treatment with TNF-{alpha} blocking drugs using a novel flow-cytometric interferon-{gamma} release assay. Rheumatology (Oxford) 47: 212-218 [Abstract] [Full Text]  
• Gordon, R. J., Lowy, F. D. (2005). Bacterial infections in drug users.. NEJM 353: 1945-1954 [Full Text]  
• (2005). American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: Controlling Tuberculosis in the United States. Am. J. Respir. Crit. Care Med. 172: 1169-1227 [Full Text]  
• Borkow, G., Bentwich, Z. (2004). Chronic Immune Activation Associated with Chronic Helminthic and Human Immunodeficiency Virus Infections: Role of Hyporesponsiveness and Anergy. Clin. Microbiol. Rev. 17: 1012-1030 [Abstract] [Full Text]  
• Gothi, D, Joshi, J M (2004). Clinical and laboratory observations of tuberculosis at a Mumbai (India) clinic. Postgrad. Med. J. 80: 97-100 [Abstract] [Full Text]  
• Nguyen, C. (2004). A young man with an expanding neck mass. CMAJ 170: 193-193 [Full Text]  
• Shams, H., Barnes, P. F., Weis, S. E., Klucar, P., Wizel, B. (2003). Human CD8+ T cells recognize epitopes of the 28-kDa hemolysin and the 38-kDa antigen of Mycobacterium tuberculosis. J. Leukoc. Biol. 74: 1008-1014 [Abstract] [Full Text]  
• Cahn, P., Perez, H., Ben, G., Ochoa, C. (2003). Tuberculosis and HIV: A Partnership Against the Most Vulnerable. J Int Assoc Physicians AIDS Care (Chic Ill) 2: 106-123 [Abstract]  
• Silver, R. F., Zukowski, L., Kotake, S., Li, Q., Pozuelo, F., Krywiak, A., Larkin, R. (2003). Recruitment of Antigen-Specific Th1-Like Responses to the Human Lung following Bronchoscopic Segmental Challenge with Purified Protein Derivative of Mycobacterium tuberculosis. Am. J. Respir. Cell Mol. Bio. 29: 117-123 [Abstract] [Full Text]  
• Rocha, M., Pereira, S., Ferreira, L., Barros, H. (2003). The role of adherence in tuberculosis HIV-positive patients treated in ambulatory regimen. Eur Respir J 21: 785-788 [Abstract] [Full Text]  
• Patel, V., Bhigjee, A., Bill, P., Connolly, C. (2003). Cytokine profiles in HIV seropositive patients with tuberculous meningitis. Sex. Transm. Infect. 79: 75-76 [Full Text]  
• Patel, V., Bhigjee, A., Bill, P., Connolly, C. (2002). Cytokine profiles in HIV seropositive patients with tuberculous meningitis. J. Neurol. Neurosurg. Psychiatry 73: 598-599 [Full Text]  
• Dullaghan, E. M., Malloff, C. A., Li, A. H., Lam, W. L., Stokes, R. W. (2002). Two-dimensional bacterial genome display: a method for the genomic analysis of mycobacteria. Microbiology 148: 3111-3117 [Abstract] [Full Text]  
• Bouchonnet, F., Boechat, N., Bonay, M., Hance, A. J. (2002). Alpha/Beta Interferon Impairs the Ability of Human Macrophages To Control Growth of Mycobacterium bovis BCG. Infect. Immun. 70: 3020-3025 [Abstract] [Full Text]  
• Bruchfeld, J., Aderaye, G., Palme, I. B., Bjorvatn, B., Ghebremichael, S., Hoffner, S., Lindquist, L. (2002). Molecular Epidemiology and Drug Resistance of Mycobacterium tuberculosis Isolates from Ethiopian Pulmonary Tuberculosis Patients with and without Human Immunodeficiency Virus Infection. J. Clin. Microbiol. 40: 1636-1643 [Abstract] [Full Text]  
• Caviedes, L., Delgado, J., Gilman, R. H. (2002). Tetrazolium Microplate Assay as a Rapid and Inexpensive Colorimetric Method for Determination of Antibiotic Susceptibility of Mycobacterium tuberculosis. J. Clin. Microbiol. 40: 1873-1874 [Abstract] [Full Text]  
• Smith, N P, Pozniak, A L (2002). The changing face of HIV. Imaging 14: 1-7 [Abstract] [Full Text]  
• (2002). Tuberculosis and HIV. AIDS Clin Care 2002: 6-6 [Full Text]  
• CARVALHO, A. C. C., DERIEMER, K., NUNES, Z. B., MARTINS, M., COMELLI, M., MARINONI, A., KRITSKI, A. L. (2001). Transmission of Mycobacterium tuberculosis to Contacts of HIV-infected Tuberculosis Patients. Am. J. Respir. Crit. Care Med. 164: 2166-2171 [Abstract] [Full Text]  
• Shen, Y., Shen, L., Sehgal, P., Zhou, D., Simon, M., Miller, M., Enimi, E. A., Henckler, B., Chalifoux, L., Sehgal, N., Gastron, M., Letvin, N. L., Chen, Z. W. (2001). Antiretroviral Agents Restore Mycobacterium-Specific T-Cell Immune Responses and Facilitate Controlling a Fatal Tuberculosis-Like Disease in Macaques Coinfected with Simian Immunodeficiency Virus and Mycobacterium bovis BCG. J. Virol. 75: 8690-8696 [Abstract] [Full Text]  
• Schwebach, J. R., Casadevall, A., Schneerson, R., Dai, Z., Wang, X., Robbins, J. B., Glatman-Freedman, A. (2001). Expression of a Mycobacterium tuberculosis Arabinomannan Antigen In Vitro and In Vivo. Infect. Immun. 69: 5671-5678 [Abstract] [Full Text]  
• Long, R. (2001). Smear-Negative Pulmonary Tuberculosis in Industrialized Countries. Chest 120: 330-334 [Full Text]  
• MAYAUD, C, CADRANEL, J (2001). AIDS and the lung in a changing world. Thorax 56: 423-426 [Full Text]  
• Boechat, N., Bouchonnet, F., Bonay, M., Grodet, A., Pelicic, V., Gicquel, B., Hance, A. J. (2001). Culture at High Density Improves the Ability of Human Macrophages to Control Mycobacterial Growth. J. Immunol. 166: 6203-6211 [Abstract] [Full Text]  
• Brill, K. J., Li, Q., Larkin, R., Canaday, D. H., Kaplan, D. R., Boom, W. H., Silver, R. F. (2001). Human Natural Killer Cells Mediate Killing of Intracellular Mycobacterium tuberculosis H37Rv via Granule-Independent Mechanisms. Infect. Immun. 69: 1755-1765 [Abstract] [Full Text]  
• CUNNINGHAM, E. T JR, RATHINAM, S R (2001). TB or not TB? The perennial question. Br J Ophthalmol 85: 127-128 [Full Text]  
• Hendrickson, R. C., Douglass, J. F., Reynolds, L. D., McNeill, P. D., Carter, D., Reed, S. G., Houghton, R. L. (2000). Mass Spectrometric Identification of Mtb81, a Novel Serological Marker for Tuberculosis. J. Clin. Microbiol. 38: 2354-2361 [Abstract] [Full Text]  
• Lauzardo, M., Ashkin, D. (2000). Phthisiology at the Dawn of the New Century. Chest 117: 1455-1473 [Abstract] [Full Text]  
• Zumla, A., Malon, P., Henderson, J., Grange, J. M (2000). Impact of HIV infection on tuberculosis. Postgrad. Med. J. 76: 259-268 [Abstract] [Full Text]  
• Bennett, C. L., Schwartz, D. N., Parada, J. P., Sipler, A. M., Chmiel, J. S., DeHovitz, J. A., Goetz, M. B., Weinstein, R. A. (2000). Delays in Tuberculosis Isolation and Suspicion Among Persons Hospitalized With HIV-Related Pneumonia*. Chest 117: 110-116 [Abstract] [Full Text]  
• Campion, E. W. (1999). Liberty and the Control of Tuberculosis. NEJM 340: 385-386 [Full Text]